Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04267510
Other study ID # RECHMPL20_0085
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2013
Est. completion date January 1, 2020

Study information

Verified date February 2020
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The etiology of osteoarthritis is varied, ranging from multifactorial, environmental to monogenic. In individuals in whom osteoarthritis appears earlier than in the general population, it is called early osteoarthritis. To our knowledge, there are no large-scale genetic studies on people with early osteoarthritis. The investigators therefore sought to study the causes of monogenic osteoarthritis in people suffering from early non-syndromic osteoarthritis.

Material and method From 2013 to 2019, experts in constitutional bone disease sent patients with non-syndromic early osteoarthritis for genetic analysis to our center of competence for constitutional bone diseases. The sequencing of a panel of genes was carried out by NGS.


Recruitment information / eligibility

Status Completed
Enrollment 65
Est. completion date January 1, 2020
Est. primary completion date December 1, 2019
Accepts healthy volunteers No
Gender All
Age group 7 Years and older
Eligibility Inclusion Criteria:

- Patients with early osteoarthritis who have undergone genetic sequencing

Exclusion Criteria:

- Patients refusing to participate in research

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France UH Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary identification of genetic mutation sequencing out by NGS 1 day
Primary number of genetic mutation sequencing out by NGS 1 day
See also
  Status Clinical Trial Phase
Completed NCT01747018 - Platelet Rich Plasma Injection for Knee Pain Phase 1/Phase 2